Search research articles
Contact Us
Filters
Showing results (21-30 of 178) with videos related to
Page
of 18
Sort By:
Gynecologic Oncology
|
February 4, 2018
A collagen-fibrin patch for the prevention of symptomatic lymphoceles after pelvic lymphadenectomy in women with gynecologic malignancies: A randomized clinical trial
Christoph Grimm, Stephan Polterauer, Samir Helmy-Bader, et al.
Gynecologic Oncology
|
November 20, 2016
Intake of selective beta blockers has no impact on survival in patients with epithelial ovarian cancer
Florian Heitz, Alexandra Hengsbach, Philipp Harter, et al.
Gynecologic Oncology
|
May 22, 2016
The revised 2014 FIGO staging system for epithelial ovarian cancer: Is a subclassification into FIGO stage IVA and IVB justified?
Beyhan Ataseven, Philipp Harter, Christoph Grimm, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 2009
Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases
Florian Heitz, Philipp Harter, Hans-Joachim Lueck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2012
Requirements to assess feasibility of phase 0 trials during major abdominal surgery: variability of PARP activity
Florian Heitz, Andreas du Bois, Justine Rochon, et al.
Gynecologic Oncology
|
July 13, 2015
Pre-operative serum albumin is associated with post-operative complication rate and overall survival in patients with epithelial ovarian cancer undergoing cytoreductive surgery
Beyhan Ataseven, Andreas du Bois, Alexander Reinthaller, et al.
Annals of Surgical Oncology
|
April 11, 2018
Stage- and Histologic Subtype-Dependent Frequency of Lymph Node Metastases in Patients with Epithelial Ovarian Cancer Undergoing Systematic Pelvic and Paraaortic Lymphadenectomy
Florian Heitz, Philipp Harter, Beyhan Ataseven, et al.
Gynecologic Oncology
|
January 28, 2014
Prognostic and predictive value of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) score in surgery for recurrent ovarian cancer
Philipp Harter, Bianca Beutel, Piero F Alesina, et al.
Archives of Gynecology and Obstetrics
|
May 21, 2015
Systematic pelvic and paraaortic lymphadenectomy in early high-risk or advanced endometrial cancer
Christina Fotopoulou, Ahmed El-Balat, Andreas du Bois, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 9, 2010
Abdominal wall metastases in patients with ovarian cancer after laparoscopic surgery: incidence, risk factors, and complications
Florian Heitz, Dejan Ognjenovic, Philipp Harter, et al.
Page
of 18
Search research articles
Search
Showing results (21-30 of 178) with videos related to
Sort By:
Page
of 18
Gynecologic Oncology
|
February 4, 2018
A collagen-fibrin patch for the prevention of symptomatic lymphoceles after pelvic lymphadenectomy in women with gynecologic malignancies: A randomized clinical trial
Christoph Grimm, Stephan Polterauer, Samir Helmy-Bader, et al.
Gynecologic Oncology
|
November 20, 2016
Intake of selective beta blockers has no impact on survival in patients with epithelial ovarian cancer
Florian Heitz, Alexandra Hengsbach, Philipp Harter, et al.
Gynecologic Oncology
|
May 22, 2016
The revised 2014 FIGO staging system for epithelial ovarian cancer: Is a subclassification into FIGO stage IVA and IVB justified?
Beyhan Ataseven, Philipp Harter, Christoph Grimm, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 2009
Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases
Florian Heitz, Philipp Harter, Hans-Joachim Lueck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2012
Requirements to assess feasibility of phase 0 trials during major abdominal surgery: variability of PARP activity
Florian Heitz, Andreas du Bois, Justine Rochon, et al.
Gynecologic Oncology
|
July 13, 2015
Pre-operative serum albumin is associated with post-operative complication rate and overall survival in patients with epithelial ovarian cancer undergoing cytoreductive surgery
Beyhan Ataseven, Andreas du Bois, Alexander Reinthaller, et al.
Annals of Surgical Oncology
|
April 11, 2018
Stage- and Histologic Subtype-Dependent Frequency of Lymph Node Metastases in Patients with Epithelial Ovarian Cancer Undergoing Systematic Pelvic and Paraaortic Lymphadenectomy
Florian Heitz, Philipp Harter, Beyhan Ataseven, et al.
Gynecologic Oncology
|
January 28, 2014
Prognostic and predictive value of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) score in surgery for recurrent ovarian cancer
Philipp Harter, Bianca Beutel, Piero F Alesina, et al.
Archives of Gynecology and Obstetrics
|
May 21, 2015
Systematic pelvic and paraaortic lymphadenectomy in early high-risk or advanced endometrial cancer
Christina Fotopoulou, Ahmed El-Balat, Andreas du Bois, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 9, 2010
Abdominal wall metastases in patients with ovarian cancer after laparoscopic surgery: incidence, risk factors, and complications
Florian Heitz, Dejan Ognjenovic, Philipp Harter, et al.
Page
of 18